Maxim A. Moroz

729 total citations
19 papers, 558 citations indexed

About

Maxim A. Moroz is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Maxim A. Moroz has authored 19 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Maxim A. Moroz's work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (8 papers) and Cancer Research and Treatments (3 papers). Maxim A. Moroz is often cited by papers focused on Virus-based gene therapy research (9 papers), CAR-T cell therapy research (8 papers) and Cancer Research and Treatments (3 papers). Maxim A. Moroz collaborates with scholars based in United States, Russia and Netherlands. Maxim A. Moroz's co-authors include Ronald G. Blasberg, Inna Serganova, Vladimir Ponomarev, Juan Zurita, Larissa Shenker, Hanwen Zhang, Ekaterina Moroz, Jason T. Lee, Mikhail Doubrovin and Jose Lobo and has published in prestigious journals such as Biomaterials, Cancer Research and Clinical Cancer Research.

In The Last Decade

Maxim A. Moroz

19 papers receiving 550 citations

Peers

Maxim A. Moroz
Patrick C. Gedeon United States
Chi-Ping Day United States
Michael R. Weist United States
Chien-Tsun Kuan United States
Patrick C. Gedeon United States
Maxim A. Moroz
Citations per year, relative to Maxim A. Moroz Maxim A. Moroz (= 1×) peers Patrick C. Gedeon

Countries citing papers authored by Maxim A. Moroz

Since Specialization
Citations

This map shows the geographic impact of Maxim A. Moroz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim A. Moroz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim A. Moroz more than expected).

Fields of papers citing papers by Maxim A. Moroz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim A. Moroz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim A. Moroz. The network helps show where Maxim A. Moroz may publish in the future.

Co-authorship network of co-authors of Maxim A. Moroz

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim A. Moroz. A scholar is included among the top collaborators of Maxim A. Moroz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim A. Moroz. Maxim A. Moroz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nguyen, Dung, Dimitrios Dionyssiou, Tatiana S. Zaitseva, et al.. (2023). Development of a rat model of lymphedema and the implantation of a collagen-based medical device for therapeutic intervention. Frontiers in Cardiovascular Medicine. 10. 1214116–1214116. 4 indexed citations
2.
Moroz, Maxim A., Juan Zurita, Konstantin Dobrenkov, et al.. (2021). Introducing a new reporter gene, membrane-anchored Cypridina luciferase, for multiplex bioluminescence imaging. Molecular Therapy — Oncolytics. 21. 15–22. 10 indexed citations
3.
Hocine, Hocine R., Maxim A. Moroz, Srijita Banerjee, et al.. (2021). Imaging CAR T-cell kinetics in solid tumors: Translational implications. Molecular Therapy — Oncolytics. 22. 355–367. 30 indexed citations
4.
Harmsen, Stefan, Emin İlker Medine, Maxim A. Moroz, et al.. (2020). A dual-modal PET/near infrared fluorescent nanotag for long-term immune cell tracking. Biomaterials. 269. 120630–120630. 50 indexed citations
5.
Moroz, Maxim A., Pat Zanzonico, Jason T. Lee, & Vladimir Ponomarev. (2018). Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes. Methods in molecular biology. 1790. 153–163. 7 indexed citations
6.
Lee, Jason T., Maxim A. Moroz, & Vladimir Ponomarev. (2018). Imaging T Cell Dynamics and Function Using PET and Human Nuclear Reporter Genes. Methods in molecular biology. 1790. 165–180. 4 indexed citations
7.
Lee, Jason T., Hanwen Zhang, Maxim A. Moroz, et al.. (2016). Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging. Molecular Imaging and Biology. 19(1). 100–108. 17 indexed citations
8.
Serganova, Inna, Ekaterina Moroz, Ivan Cohen, et al.. (2016). Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade. Molecular Therapy — Oncolytics. 4. 41–54. 72 indexed citations
9.
Moroz, Maxim A., Hanwen Zhang, Jason T. Lee, et al.. (2015). Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes. Journal of Nuclear Medicine. 56(7). 1055–1060. 64 indexed citations
10.
Moroz, Maxim A., et al.. (2015). A New approach to SNAP‐tag technology as a possible imaging tool for translational research. The FASEB Journal. 29(S1). 1 indexed citations
11.
Moroz, Maxim A., et al.. (2015). Approaches to the Assessment of the Contribution of Tourism Into the Regional Surplus Product: Case of the Kaliningrad Region. Mediterranean Journal of Social Sciences. 6 indexed citations
12.
Moroz, Maxim A., Shangde Cai, Jayasree S. Nair, et al.. (2011). Imaging Colon Cancer Response Following Treatment with AZD1152: A Preclinical Analysis of [18F]Fluoro-2-deoxyglucose and 3′-deoxy-3′-[18F]Fluorothymidine Imaging. Clinical Cancer Research. 17(5). 1099–1110. 28 indexed citations
13.
Moroz, Maxim A., Ruimin Huang, Weiji Shi, et al.. (2011). Comparison of Corticotropin-Releasing Factor, Dexamethasone, and Temozolomide: Treatment Efficacy and Toxicity in U87 and C6 Intracranial Gliomas. Clinical Cancer Research. 17(10). 3282–3292. 28 indexed citations
14.
Zhang, Hanwen, Maxim A. Moroz, Inna Serganova, et al.. (2010). Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC. Journal of Nuclear Medicine. 52(1). 123–131. 59 indexed citations
15.
Doubrovin, Mikhail, Maxim A. Moroz, Malgorzata Olszewska, et al.. (2010). Preclinical Evaluation Of Human Nor-Epinephrine Transporter (hNET)/MIBG Reporter System For Imaging Adoptively Transferred EBV-Specific Cytotoxic T-Lymphocites. Biology of Blood and Marrow Transplantation. 16(2). S268–S269. 1 indexed citations
16.
Serganova, Inna, Ekaterina Moroz, Jelena Vider, et al.. (2009). Multimodality imaging of TGFβ signaling in breast cancer metastases. The FASEB Journal. 23(8). 2662–2672. 45 indexed citations
17.
Moroz, Maxim A., Inna Serganova, Pat Zanzonico, et al.. (2007). Imaging hNET Reporter Gene Expression with 124I-MIBG. Journal of Nuclear Medicine. 48(5). 827–836. 80 indexed citations
18.
Solit, David B., Elmer Santos, Christine A. Pratilas, et al.. (2007). 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition. Cancer Research. 67(23). 11463–11469. 48 indexed citations
19.
Serganova, Inna, Ekaterina Moroz, Maxim A. Moroz, Nagavarakishore Pillarsetty, & Ronald G. Blasberg. (2006). Non-invasive molecular imaging and reporter genes. Open Life Sciences. 1(1). 88–123. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026